Studying cancer in context to stop its growth
MIT spinout Kronos Bio, founded by Associate Professor Angela Koehler, studies the complex signaling networks of cancer cells to find new drug targets.
An implantable device could enable injection-free control of diabetes
The device contains encapsulated cells that produce insulin, plus a tiny oxygen-producing factory that keeps the cells healthy.
Study explains why certain immunotherapies don’t always work as predicted
The findings could help doctors identify cancer patients who would benefit the most from drugs called checkpoint blockade inhibitors.
Smart pill can track key biological markers in real-time
Coupling engineered bacteria with low-power electronics could be highly effective in diagnosis, treatment of bowel diseases.
MIT engineers design more powerful RNA vaccines
The new approach could lead to intranasal vaccines for Covid-19 and other respiratory diseases.
The tenured engineers of 2023
Nine faculty members have been granted tenure in six units across MIT’s School of Engineering.
A snapshot of cancer vaccine development
The Koch Institute’s Annual Symposium highlights emerging successes and challenges in the advancement of vaccines to prevent and treat cancer.
Fourteen MIT School of Science professors receive tenure for 2022 and 2023
Faculty members were recently granted tenure in the departments of Biology, Brain and Cognitive Sciences, Chemistry, EAPS, and Physics.
Study finds a surprising new role for a major immune regulator
In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.
Making sense of cell fate
MIT researchers find timing and dosage of DNA-damaging drugs are key to whether a cancer cell dies or enters senescence.
A new vision for ultrasound imaging
Ultrasound research specialist and 2023 MIT Excellence Award winner Nicole Henning adapts ultrasound technology for more sensitive, less invasive imaging for disease modeling.
Angela Koehler appointed faculty director of the Deshpande Center
A biotech entrepreneur, Koehler will help faculty and students launch startups and bring new products to market through the MIT Deshpande Center for Technological Innovation.
Vaccine delivers a boost to T cell therapy
The new strategy may enable engineered T cells to eradicate solid tumors such as glioblastoma.
Surprise! Weaker bonds can make polymers stronger
By adding weak linkers to a polymer network, chemists dramatically enhanced the material’s resistance to tearing.
Novo Nordisk to support MIT postdocs working at the intersection of AI and life sciences
MIT-Novo Nordisk Artificial Intelligence Postdoctoral Fellows Program will support up to 10 postdocs annually over five years.